Alps Group Inc (ALPS)

Alps Group Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Alps Group Inc (ALPS) is a Biotechnology company based in MY with a market capitalization of $79.5M. Revenue grew 40.3% year-over-year and free cash flow was negative at -$1.7M. This page tracks ALPS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

MY · 2 employees · IPO Oct 31, 2025

Valuation

Valuation & price

$0.71as of May 26, 2026· -94.1% vs 52w high

P/E ratio

Latest-FY diluted EPS

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$12.01$6.29$0.58Oct 25Mar 26Jul 26
$0.5852-week range$12.01
Loading valuation history…

Fundamentals

Key fundamentals

$79.5M

Market cap

40.3%

Revenue growth (YoY)

38.6%

Gross margin

-$1.7M

Free cash flow (USD)

$131.7K

Net debt

2669.8%

Share dilution

0/3

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20212025

$0$3.4M

Free cash flow by year

20212025

-$324.9K-$1.7M

Gross margin by year

20222025

55.0%38.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 23, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingJun 23, 2026Filing

    Patient-Derived Organoid Program Launch

  • 6-K filingJun 9, 2026Filing

    Accreditation Announcement

  • 6-K filingMay 19, 2026Filing

    Regulatory Update

  • 6-K filingApr 17, 2026Filing

    Management Change

Questions

Frequently asked questions

What is Alps Group Inc's market cap?

Alps Group Inc (ALPS) has a market capitalization of $79.5M.

What is ALPS's P/E ratio?

A meaningful P/E ratio is not available for ALPS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Alps Group Inc last report earnings?

ALPS last reported earnings on June 23, 2026; the next date is not yet scheduled.

Are insiders buying ALPS stock?

SEC Form 4 filings show no open-market insider buys at Alps Group Inc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.